Ovoca Bio reported EUR29.49M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
ALKERMES USD 167.54M 1.08M Jun/2026
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Great Western Mining Corporation EUR 231.88M 54.69M Dec/2025
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.61M 40K Jun/2026
Ovoca Bio EUR 29.49M 0 Dec/2025
Revvity USD 111.63M 174K Jun/2026
Tectonic Therapeutic USD 18.83M 92.19K Mar/2026
Viatris USD 1.16B 9.19M Jun/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026